# Systemic Propranolol for the Treatment of Paediatric Patients With Infantile Hemangiomas

> **NCT04651049** · — · COMPLETED · sponsor: **Qilu Hospital of Shandong University** · enrollment: 128 (actual)

## Conditions studied

- Infantile Haemangiomas

## Interventions

- **DRUG:** propranolol
- **DEVICE:** 

## Key facts

- **NCT ID:** NCT04651049
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07-15
- **Primary completion:** 2017-12-15
- **Final completion:** 2020-02-10
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2020-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04651049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04651049, "Systemic Propranolol for the Treatment of Paediatric Patients With Infantile Hemangiomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04651049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*